These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36803019)
1. Evaluation of Response to High-Dose Intravenous Vitamin K Administration. Chapman AR; Yerke JR; Lumpkin M; Rudoni MA; Militello M; Wang L; Bass SN Ann Pharmacother; 2023 Oct; 57(10):1178-1184. PubMed ID: 36803019 [TBL] [Abstract][Full Text] [Related]
2. The effectiveness of intravenous vitamin K in correcting cirrhosis-associated coagulopathy. Rivosecchi RM; Kane-Gill SL; Garavaglia J; MacLasco A; Johnson H Int J Pharm Pract; 2017 Dec; 25(6):463-465. PubMed ID: 28211589 [TBL] [Abstract][Full Text] [Related]
3. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10. Gunther KE; Conway G; Leibach L; Crowther MA Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584 [TBL] [Abstract][Full Text] [Related]
5. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting. Tsu LV; Dienes JE; Dager WE Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study. Bussey HI; Bussey M; Bussey-Smith KL; Frei CR Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412 [TBL] [Abstract][Full Text] [Related]
7. Subcutaneous phytonadione for reversal of warfarin-induced elevation of the International Normalized Ratio. Byrd DC; Stephens MA; Hamann GL; Dorko C Am J Health Syst Pharm; 1999 Nov; 56(22):2312-5. PubMed ID: 10582823 [TBL] [Abstract][Full Text] [Related]
8. Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study. Al Sulaiman K; Al Mutairi M; Al Harbi O; Al Duraihim A; Aldosary S; Al Khalil H; Al Shaya A; Al Harbi S; Alotaibi N; Al Aamer K; Vishwakarma R; Al Asiri M; Aljuhani O; Al Katheri A; Al Bekairy AM Clin Appl Thromb Hemost; 2021; 27():10760296211050923. PubMed ID: 34806430 [TBL] [Abstract][Full Text] [Related]
9. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis. Dezee KJ; Shimeall WT; Douglas KM; Shumway NM; O'malley PG Arch Intern Med; 2006 Feb; 166(4):391-7. PubMed ID: 16505257 [TBL] [Abstract][Full Text] [Related]
10. Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage. Cicci CD; Weiss A; Dang C; Stanton M; Feldman R Pharmacotherapy; 2022 May; 42(5):366-374. PubMed ID: 35384000 [TBL] [Abstract][Full Text] [Related]
11. Randomized, placebo-controlled trial of orally administered vitamin K1 for warfarin-associated coagulopathy in Chinese patients with mechanical heart valves. Zhang H; Li M; Ao XL; Dong YJ; Dong L Eur J Clin Pharmacol; 2021 Sep; 77(9):1333-1339. PubMed ID: 33783553 [TBL] [Abstract][Full Text] [Related]
12. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study. Lubetsky A; Yonath H; Olchovsky D; Loebstein R; Halkin H; Ezra D Arch Intern Med; 2003 Nov; 163(20):2469-73. PubMed ID: 14609783 [TBL] [Abstract][Full Text] [Related]
13. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial. Crowther MA; Julian J; McCarty D; Douketis J; Kovacs M; Biagoni L; Schnurr T; McGinnis J; Gent M; Hirsh J; Ginsberg J Lancet; 2000 Nov; 356(9241):1551-3. PubMed ID: 11075768 [TBL] [Abstract][Full Text] [Related]
14. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding. Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715 [TBL] [Abstract][Full Text] [Related]
15. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices. Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417 [TBL] [Abstract][Full Text] [Related]
16. Impact of Vitamin K Administration on INR Changes and Bleeding Events Among Patients With Cirrhosis. Meyer AV; Green M; Pautler HM; Korenblat K; Deal EN; Thoelke MS Ann Pharmacother; 2016 Feb; 50(2):113-7. PubMed ID: 26586854 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial. Kampouraki E; Avery PJ; Wynne H; Biss T; Hanley J; Talks K; Kamali F Br J Haematol; 2017 Sep; 178(5):800-809. PubMed ID: 28771671 [TBL] [Abstract][Full Text] [Related]
18. Impact of Vitamin K Administration on Elevated International Normalized Ratio in Chronic Liver Disease. Smith CB; Hennessey EK; Crossey CD; Crannage AJ Clin Appl Thromb Hemost; 2023; 29():10760296231164642. PubMed ID: 37093741 [TBL] [Abstract][Full Text] [Related]
19. Protocolized use of Factor Eight Inhibitor Bypassing Activity (FEIBA) for the reversal of warfarin induced coagulopathy. Htet NN; Barounis D; Knight C; Umunna BP; Hormese M; Lovell E Am J Emerg Med; 2020 Mar; 38(3):539-544. PubMed ID: 31176578 [TBL] [Abstract][Full Text] [Related]
20. The use of vitamin K in patients on anticoagulant therapy: a practical guide. Hanslik T; Prinseau J Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]